Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Journal of Labelled Compounds & Radiopharmaceuticals
|
April 30, 2019
Deuterated active pharmaceutical ingredients: A science-based proposal for synthesis, analysis, and control. Part 1: Framing the problem
Boris Czeskis, Charles S Elmore, Anthony Haight, et al.
European Journal of Pharmacology
|
November 27, 2002
Identification of full, partial and inverse CC chemokine receptor 3 agonists using [35S]GTPgammaS binding
Yuntao Wan, James P Jakway, Hongchen Qiu, et al.
The Journal of Biological Chemistry
|
February 4, 2010
SCH529074, a small molecule activator of mutant p53, which binds p53 DNA binding domain (DBD), restores growth-suppressive function to mutant p53 and interrupts HDM2-mediated ubiquitination of wild type p53
Mark Demma, Eugene Maxwell, Robert Ramos, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 15, 2007
Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist
Waldemar Gonsiorek, Xuedong Fan, David Hesk, et al.
Analytical Biochemistry
|
November 6, 2016
Quantitation of wall teichoic acid in Staphylococcus aureus by direct measurement of monomeric units using LC-MS/MS
Olga Berejnaia, Hao Wang, Marc Labroli, et al.
Journal of Medicinal Chemistry
|
September 15, 2007
Heterotricyclic himbacine analogs as potent, orally active thrombin receptor (protease activated receptor-1) antagonists
Mariappan V Chelliah, Samuel Chackalamannil, Yan Xia, et al.
Nature
|
November 25, 2020
Metallaphotoredox aryl and alkyl radiomethylation for PET ligand discovery
Robert W Pipal, Kenneth T Stout, Patricia Z Musacchio, et al.
The Journal of Biological Chemistry
|
June 7, 2006
Characterization of peripheral human cannabinoid receptor (hCB2) expression and pharmacology using a novel radioligand, [35S]Sch225336
Waldemar Gonsiorek, David Hesk, Shu-Cheng Chen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 28, 2016
Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles
Eric D Hostetler, Abbas M Walji, Zhizhen Zeng, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2013
Discovery of an irreversible HCV NS5B polymerase inhibitor
Qingbei Zeng, Anilkumar G Nair, Stuart B Rosenblum, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Journal of Labelled Compounds & Radiopharmaceuticals
|
April 30, 2019
Deuterated active pharmaceutical ingredients: A science-based proposal for synthesis, analysis, and control. Part 1: Framing the problem
Boris Czeskis, Charles S Elmore, Anthony Haight, et al.
European Journal of Pharmacology
|
November 27, 2002
Identification of full, partial and inverse CC chemokine receptor 3 agonists using [35S]GTPgammaS binding
Yuntao Wan, James P Jakway, Hongchen Qiu, et al.
The Journal of Biological Chemistry
|
February 4, 2010
SCH529074, a small molecule activator of mutant p53, which binds p53 DNA binding domain (DBD), restores growth-suppressive function to mutant p53 and interrupts HDM2-mediated ubiquitination of wild type p53
Mark Demma, Eugene Maxwell, Robert Ramos, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 15, 2007
Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist
Waldemar Gonsiorek, Xuedong Fan, David Hesk, et al.
Analytical Biochemistry
|
November 6, 2016
Quantitation of wall teichoic acid in Staphylococcus aureus by direct measurement of monomeric units using LC-MS/MS
Olga Berejnaia, Hao Wang, Marc Labroli, et al.
Journal of Medicinal Chemistry
|
September 15, 2007
Heterotricyclic himbacine analogs as potent, orally active thrombin receptor (protease activated receptor-1) antagonists
Mariappan V Chelliah, Samuel Chackalamannil, Yan Xia, et al.
Nature
|
November 25, 2020
Metallaphotoredox aryl and alkyl radiomethylation for PET ligand discovery
Robert W Pipal, Kenneth T Stout, Patricia Z Musacchio, et al.
The Journal of Biological Chemistry
|
June 7, 2006
Characterization of peripheral human cannabinoid receptor (hCB2) expression and pharmacology using a novel radioligand, [35S]Sch225336
Waldemar Gonsiorek, David Hesk, Shu-Cheng Chen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 28, 2016
Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles
Eric D Hostetler, Abbas M Walji, Zhizhen Zeng, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2013
Discovery of an irreversible HCV NS5B polymerase inhibitor
Qingbei Zeng, Anilkumar G Nair, Stuart B Rosenblum, et al.
Page
of 4